Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation

Autor: Barone, Jordan C., Ho, Annie, Osborne, Lauren M., Eisenlohr-Moul, Tory A., Morrow, A. Leslie, Payne, Jennifer L., Epperson, C. Neill, Hantsoo, Liisa
Zdroj: In Psychoneuroendocrinology November 2024 169
Databáze: ScienceDirect
Externí odkaz: